News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,026 Results
Type
Article (40924)
Company Profile (293)
Press Release (652809)
Section
Business (206029)
Career Advice (2020)
Deals (35675)
Drug Delivery (85)
Drug Development (81174)
Employer Resources (168)
FDA (16218)
Job Trends (14995)
News (347913)
Policy (32894)
Tag
Academia (2612)
Alliances (49888)
Alzheimer's disease (1240)
Approvals (16149)
Artificial intelligence (131)
Bankruptcy (356)
Best Places to Work (11603)
Biotechnology (207)
Breast cancer (120)
Cancer (1088)
Cardiovascular disease (99)
Career advice (1689)
Cell therapy (232)
Clinical research (64429)
Collaboration (389)
Compensation (197)
COVID-19 (2580)
C-suite (96)
Data (1122)
Diabetes (152)
Diagnostics (6309)
Earnings (85259)
Employer resources (146)
Events (110253)
Executive appointments (311)
FDA (16754)
Funding (355)
Gene therapy (178)
GLP-1 (586)
Government (4372)
Healthcare (18803)
Infectious disease (2666)
Inflammatory bowel disease (106)
Interviews (312)
IPO (16367)
Job creations (3745)
Job search strategy (1444)
Layoffs (415)
Legal (7971)
Lung cancer (173)
Manufacturing (177)
Medical device (13239)
Medtech (13244)
Mergers & acquisitions (19382)
Metabolic disorders (403)
Neuroscience (1515)
NextGen Class of 2024 (6537)
Non-profit (4520)
Northern California (1479)
Obesity (232)
Opinion (182)
Patents (102)
People (56902)
Phase I (20025)
Phase II (28361)
Phase III (21152)
Pipeline (457)
Postmarket research (2574)
Preclinical (8609)
Radiopharmaceuticals (237)
Rare diseases (219)
Real estate (6100)
Regulatory (21819)
Research institute (2370)
Resumes & cover letters (350)
Southern California (1304)
Startups (3607)
United States (13522)
Vaccines (552)
Weight loss (168)
Date
Today (131)
Last 7 days (797)
Last 30 days (3806)
Last 365 days (35831)
2024 (32865)
2023 (40331)
2022 (51424)
2021 (56015)
2020 (54496)
2019 (46960)
2018 (35321)
2017 (32506)
2016 (31974)
2015 (37999)
2014 (31857)
2013 (26978)
2012 (29100)
2011 (29777)
2010 (27816)
Location
Africa (729)
Arizona (194)
Asia (37920)
Australia (6196)
California (3331)
Canada (1290)
China (247)
Colorado (146)
Connecticut (152)
Europe (81511)
Florida (458)
Georgia (117)
Illinois (343)
Indiana (197)
Kansas (96)
Maryland (581)
Massachusetts (2606)
Michigan (157)
Minnesota (277)
New Jersey (959)
New York (962)
North Carolina (717)
Northern California (1479)
Ohio (140)
Pennsylvania (845)
South America (1121)
Southern California (1304)
Texas (466)
Utah (91)
Washington State (363)
694,026 Results for "kraig biocraft laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth
Kraig Biocraft Laboratories, Inc., announces that it has achieved full capacity at its current production location. Hitting this milestone was part of Kraig Labs’ expansion plans for the first half of 2024.
July 1, 2024
·
2 min read
BioMidwest
Kraig Biocraft Laboratories Increases Spider Silk Production with Next Generation of Hybrid Eggs Completed
Kraig Biocraft Laboratories, Inc., announces that it has expanded its production of spider silk with the creation of the next generation of BAM-1 hybrid.
June 25, 2024
·
2 min read
BioMidwest
Kraig Biocraft Laboratories Announces BAM-1 Spider Silk Hybrids are in Production
Kraig Biocraft Laboratories, Inc., announces that Kraig Labs is now in production with its BAM-1 recombinant spider silk hybrids.
June 3, 2024
·
3 min read
Kraig Biocraft Laboratories Announces Intention to Diversify and Expand its Production Base
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), announces today that it is pursuing a possible business expansio
May 13, 2024
·
2 min read
BioMidwest
Kraig Biocraft Laboratories Announces Production Update for BAM-1 Spider Silk Hybrids
Kraig Biocraft Laboratories, Inc., announces that production of its BAM-1 spider silk hybrid strain continues to set records for silkworm size, growth, and robustness.
June 11, 2024
·
2 min read
BioMidwest
Kraig Biocraft Laboratories Shares Update on Dragon Silk Production Utilizing the BAM-1 Platform
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”) announces an update on the commercialization of its BAM-1 recombinant spider silk production hybrids.
May 28, 2024
·
3 min read
Kraig Biocraft Laboratories Prepares to Accelerate Production Launch following Spring Trials Success
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), announces today that it has completed its analysis of its spring spider silk production trials
May 20, 2024
·
3 min read
BioMidwest
Kraig Biocraft Laboratories Successfully Completes Cocooning in First Commercial Production Run of BAM-1 Spider Silk Hybrids
Kraig Biocraft Laboratories, Inc., announces that it has successfully completed cocoon production for the first commercial production run of its BAM-1 hybrids.
June 17, 2024
·
3 min read
BioMidwest
Kraig Biocraft Laboratories Spring Spider Silk Production Trials Exceed Expectations
Kraig Biocraft Laboratories, Inc., announces that the spring production trials of the Company’s new BAM-1 hybrid parental strains have concluded, exceeding all expectations for scale, performance and robustness.
May 9, 2024
·
4 min read
Business
Kraig Biocraft Laboratories Provides a Statement on the Market Response to Recent Company Milestones and Shareholder Communications
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“Company”), announces that it remains proud to share information relating to its recent progress and the resounding success of the spring production trials.
May 16, 2024
·
4 min read
1 of 69,403
Next
